GSB
RGC icon

Greenfield Savings Bank’s Regencell Bioscience RGC Stock Holding History

Greenfield Savings Bank’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,000
Closed -$187K – 152
2025
Q2 		$187K Buy
+11,000
New +$134K 0.09% 145

Other funds holding RGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VA
Vident Advisory Alpharetta, Georgia $11.7B AUM 37.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Greenfield Savings Bank's RGC Position: Q3 2025 in Review

Greenfield Savings Bank sold out of Regencell Bioscience (RGC) in Q3 2025, closing a stake of 11,000 shares — an estimated $187K sold.

Greenfield Savings Bank first reported a position in RGC in Q2 2025 and held it in 1 quarter. The position peaked at $187K in Q2 2025. 16 funds tracked by Wall St. Rank hold RGC as of Q3 2025.

  • Greenfield Savings Bank reported no remaining Regencell Bioscience position as of Q3 2025 after selling out during the quarter.
  • Greenfield Savings Bank sold 11,000 Regencell Bioscience shares in Q3 2025, an estimated $187K.
  • Greenfield Savings Bank first reported a position in Regencell Bioscience in Q2 2025 and held it in 1 quarter.
  • Greenfield Savings Bank's Regencell Bioscience position peaked at $187K in Q2 2025.
  • 16 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2025.

Based on Greenfield Savings Bank's 13F filing for Q3 2025, filed 6 Oct 2025.